Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.36
-0.02 (-6.05%)
At close: May 06, 2025, 3:59 PM
0.36
-0.06%
Pre-market: May 07, 2025, 08:31 AM EDT
Relmada Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 2. The median target predicts an increase of 177.78% from the current stock price of 0.36.
Latest Analyst Insight Report
According to 4 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
2.46M
from 0
Increased by -%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-0.95
from 0
Increased by -%
EPS Next Year
-0.8
from -0.95
Increased by 15.8%